Capricor Therapeutics, Inc. (CAPR) Institutional Ownership

Ownership Summary

Capricor Therapeutics, Inc. (NASDAQ:CAPR) has 129 institutional investors with active 13F positions as of December 2025.

• Their combined ownership stood at 59.9% of outstanding shares in December 2025, up from 32.6% in September 2025.
• They increased total shares held in Capricor Therapeutics by 102.61% from the prior quarter, while the number of investors in CAPR increased 20.56% year over year.
• Activity in CAPR broke down as 84 buyers, 41 sellers, and 4 unchanged among 129 total holders.
• In total, institutional investors held 27.39Mn shares in Capricor Therapeutics as of December 2025, up by 13.87Mn shares quarter on quarter, and up 9.31Mn shares year over year.
• SUVRETTA CAPITAL MANAGEMENT, LLC holds the largest position in CAPR at 3.82Mn shares as of December 31, 2025, or 8.35% of shares outstanding.
• Leading buyers of Capricor Therapeutics shares for the quarter ending December 2025 were SUVRETTA CAPITAL MANAGEMENT, LLC (2.03Mn), VANGUARD CAPITAL MANAGEMENT LLC (2.03Mn), TANG CAPITAL MANAGEMENT LLC (1.7Mn), State Street Corp (1.35Mn), Jones Hill Capital LP (909.21K).
• The largest sellers of Capricor Therapeutics for the quarter ending December 2025 were Point72 Asset Management, L.P. (1.02Mn), CITADEL ADVISORS LLC (362.76K), MILLENNIUM MANAGEMENT LLC (325.99K), Morgan Stanley (162.02K), FMR LLC (149.99K).
• Per Business Quant, the top 10 investors in CAPR for the quarter ending December 2025 include SUVRETTA CAPITAL MANAGEMENT, LLC (3.82Mn), BlackRock, Inc. (3.42Mn), TANG CAPITAL MANAGEMENT LLC (3.4Mn), State Street Corp (2.18Mn), VANGUARD CAPITAL MANAGEMENT LLC (2.03Mn), RA CAPITAL MANAGEMENT, L.P. (1.51Mn), GEODE CAPITAL MANAGEMENT, LLC (1.12Mn), Goldman Sachs Group Inc (911.98K), Jones Hill Capital LP (909.21K), Point72 Asset Management, L.P. (821.18K).